surmount-1 tirzepatide weight loss nondiabetic after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide vs Semaglutide: What You

Both options are available in all 50 states without insurance requirements and are HSA/FSA eligible

The idea has a superficially plausible mechanistic basis both compounds have been studied in the context of lipid metabolism, but through entirely different pathways

Reduced MTHFR activity reduced methionine regeneration reduced SAM production reduced methylation capacity across all SAM-dependent methyltransferase reactions consequences that propagate through epigenetics, neurotransmitter metabolism, creatine synthesis, phosphatidylcholine production, and the broader biochemistry that SAM sustains

Disclaimer & Disclosures Learn more about your ad choices

Appetite and Weight Loss: Central and Peripheral Mechanisms In the brain, tirzepatide engages GLP-1 and GIP pathways to reframe hunger signals: it amplifies satiety centers in the hypothalamus and brainstem, dampening reward-driven eating and reducing meal size